文献

J-GLOBAL ID：202202220011253700   整理番号：22A0938113

軽度および無症候性SARS-CoV-2感染を検出するための核蛋白質に対する血清陽性:COVID-19ワクチン接種後のブレークスルー感染を検出するための補完ツールか

Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?

著者 (21件)： van den Hoogen Lotus L. (Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands) ,  Smits Gaby (Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands) ,  van Hagen Cheyenne C.E. (Centre for Infectious Diseases, Epidemiology and Surveillance, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands) ,  Wong Denise (Centre for Infectious Diseases, Epidemiology and Surveillance, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands) ,  Vos Eric R.A. (Centre for Infectious Diseases, Epidemiology and Surveillance, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands) ,  van Boven Michiel (Centre for Infectious Diseases, Epidemiology and Surveillance, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands) ,  de Melker Hester E. (Centre for Infectious Diseases, Epidemiology and Surveillance, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands) ,  van Vliet Jeffrey (Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands) ,  Kuijer Marjan (Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands) ,  Woudstra Linde (Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands) ,  Wijmenga-Monsuur Alienke J. (Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands) ,  GeurtsvanKessel Corine H. (Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands) ,  Stoof Susanne P. (Department of Medical Microbiology Comicro, Dijklander ziekenhuis, Hoorn, the Netherlands) ,  Reukers Daphne (Centre for Infectious Diseases Research, Diagnostics and Laboratory Surveillance, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands) ,  Wijsman Lisa A. (Centre for Infectious Diseases Research, Diagnostics and Laboratory Surveillance, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands) ,  Meijer Adam (Centre for Infectious Diseases Research, Diagnostics and Laboratory Surveillance, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands) ,  Reusken Chantal B.E.M. (Centre for Infectious Diseases Research, Diagnostics and Laboratory Surveillance, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands) ,  Rots Nynke Y. (Centre for Infectious Diseases Research, Diagnostics and Laboratory Surveillance, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands) ,  van der Klis Fiona R.M. (Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands) ,  van Binnendijk Robert S. (Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands) ,  den Hartog Gerco (Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands)
資料名： Vaccine (Web)  (Vaccine (Web))
巻： 40  号： 15  ページ： 2251-2257  発行年： 2022年 
JST資料番号： U1134A  ISSN： 0264-410X  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： アメリカ合衆国 (USA)  言語： 英語 (EN)

抄録/ポイント： 世界的に多くの国で進行中のCOVID-19ワクチンロールアウ...

シソーラス用語： ヒト ,...
準シソーラス用語： SARS-CoV-2 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=22A0938113&from=J-GLOBAL&jstjournalNo=U1134A") }}

著者キーワード (6件)： COVID-19 ,  SARS-CoV-2 ,  核蛋白質 ,  セロサーベイランス ,  免疫グロブリンG ,  多重イムノアッセイ

分類 (2件)： 感染症・寄生虫症の診断  (GD01020S) ,  血液検査  (GC02050D)

タイトルに関連する用語 (10件)： 症候 ,  SARS-CoV-2 ,  感染 ,  核蛋白質 ,  血清 ,  COVID-19 ,  ワクチン接種 ,  ブレークスルー ,  補完 ,  ツール